Categories
Change Password!
Reset Password!
Routine prophylactic paracetamol before pediatric vaccination may reduce vaccine-induced antibody responses. Symptom-based antipyretic use after vaccination preserves immunogenicity and remains the preferred approach.
According to the outcomes of a narrative review, giving paracetamol routinely before pediatric vaccination may dampen vaccine-induced antibody responses, whereas treating fever only after symptoms appear preserves immunogenicity without compromising symptom control.
Fever following childhood vaccination is a normal sign of immune activation, yet many caregivers and clinicians administer antipyretics pre-emptively to prevent discomfort. A new clinical evidence review suggests that this common practice may not always be beneficial, as suppressing the early inflammatory response can diminish the strength of vaccine-induced immunity.
Drawing on evidence from randomized clinical trials, systematic reviews, and real-world health-economic analyses, the review compared prophylactic and therapeutic use of paracetamol and ibuprofen after routine pediatric immunizations, examining their effects on fever, reactogenicity, antibody responses, and safety. The evidence showed that prophylactic paracetamol reduced post-vaccination fever. It also lowered antibody titres during the primary vaccine series, especially with pneumococcal conjugate vaccines.
Not all antipyretics showed the same pattern. Prophylactic ibuprofen was not associated with measurable suppression of vaccine immunogenicity. Although current evidence does not favor its routine preventive usage before vaccination. In contrast, administering antipyretics only after fever or discomfort develops did not affect vaccine-induced immune responses. This symptom-based strategy continued to provide clinical benefit while preserving immunogenicity.
Ibuprofen also demonstrated greater fever reduction than paracetamol in symptomatic children. Its use, however, remains inappropriate for infants younger than six months. Limited situations were also identified where prophylactic paracetamol may still be appropriate, including administration with the four-component meningococcal serogroup B vaccine and in children at increased risk of febrile seizures.
However, the findings supported a shift away from routine pre-vaccination antipyretic use and favor symptom-driven treatment to balance fever management with optimal vaccine responses.
Acta Paediatrica
Paracetamol versus Ibuprofen Before and After Paediatric Vaccination: A Clinical Evidence Review
Gianvincenzo Zuccotti et al.
Comments (0)